Showing 591-600 of 1561 results for "".
Advancing Care in Pretreated HR+/HER2- mBC
https://reachmd.com/programs/medical-industry-feature/advancing-care-in-pretreated-hrher2-mbc/16300/Dive into the data behind the approval of the first approved Trop-2-directed antibody-drug conjugate for patients with pretreated HR+/HER2- metastatic breast cancer.Supportive Care in Patients with Pretreated HR+/HER2- mBC
https://reachmd.com/programs/medical-industry-feature/supportive-care-in-patients-with-pretreated-hrher2-mbc/16301/Here’s how you can potentially manage some common side effects associated with a Trop-2–directed antibody-drug conjugate for pretreated HR+/HER2- metastatic breast cancer.Research Efforts in the Race to Find a Cure for COVID-19
https://reachmd.com/programs/covid-19-frontlines/research-efforts-in-the-race-to-find-a-cure-for-covid-19/11579/This research team shifted from studying Castleman disease to COVID-19. Could the similarities between these two diseases help uncover a cure? Could similarities between Castleman disease and COVID-19 help us find a cure?The FDA Expands Indication for Baloxavir Marboxil to Include Post-Exposure Influenza Prevention
https://reachmd.com/programs/the-drug-report/the-fda-expands-indication-for-baloxavir-marboxil-to-include-post-exposure-influenza-prevention/12043/Previously used for acute uncomplicated influenza, baloxavir marboxil has been approved by the FDA for post-exposure influenza prevention.FDA Approves Remdesivir, the First COVID-19 Treatment
https://reachmd.com/programs/the-drug-report/fda-approves-remdesivir-the-first-covid-19-treatment/11970/Learn about Remdesivir, the first FDA-approved treatment for the SARS-CoV-2 virus.Second Ebola Virus Treatment Approved
https://reachmd.com/programs/the-drug-report/second-ebola-virus-treatment-approved/12120/The FDA announced approval for a second ebolavirus treatment nearly seven years after the largest Ebola epidemic in West Africa.Novel Therapeutic & Prevention Approaches to the Novel Coronavirus
https://reachmd.com/programs/the-drug-report/novel-therapeutic-prevention-approaches-to-the-novel-coronavirus/11441/Researchers all over the world are trying many novel approaches to conquer the novel coronavirus. Here are a few of them.Another COVID-19 Vaccine Milestone Reached
https://reachmd.com/programs/the-drug-report/another-covid-19-vaccine-milestone-reached/12119/A second COVID-19 vaccination EUA approval marks another milestone in the global battle against the COVID-19 pandemic.Assessing Approvals: FDA Updates on Dexmedetomidine Hydrochloride
https://reachmd.com/programs/the-drug-report/assessing-approvals-fda-updates-on-dexmedetomidine-hydrochloride/12090/The U.S. Food and Drug Administration approves Aurobindo Pharma’s dexmedetomidine hydrochloride in 0.9% sodium chloride injection.Lawsuit Against HHS Highlights 340B Drug Pricing Dispute
https://reachmd.com/programs/the-drug-report/lawsuit-against-hhs-highlights-340b-drug-pricing-dispute/12112/A federal lawsuit against the U.S. Department of Health and Human Services alleges that the department has failed to enforce 340B pricing.